All VCT, EIS, SEIS, and Business Relief qualifying investments are high risk and are not suitable for most clients. They are illiquid investments and Investors’ capital is at risk.

Seneca Scoops Two Awards



Seneca Partners is pleased to announce success at the Insider Dealmaker Awards 2015.

Seneca Partners sister company, Acceleris Capital, won ‘AIM Deal of the Year’ for it’s work on the flotation of Redx Pharma. Chief Executive Norman Molyneux is pictured above (second from right) accepting the award from the award sponsors, Quilter Cheviot.

The judges said, “RedX Pharma has moved from a great idea into a great business. It’s got huge potential and is a good news story for the North West.”

Seneca experienced further success on the evening with Acceleris Capital’s Simon Thorn (pictured, left) being awarded ‘Young Dealmaker of the Year 2015’. Simon assisted on the Redx IPO and has worked on an impressive portfolio of deals. Simon also actively works with the Seneca EIS Portfolio.

Read more on the EIS ZONE